Literature DB >> 139916

Amino acid sequence studies on the alpha chain of human fibrinogen. Covalent structure of the alpha-chain portion of fragment D.

R F Doolittle, K G Cassman, B A Cottrell, S J Friezner, T Takagi.   

Abstract

The alpha-chain portion of fragment D has been purified from an exhaustive plasmic digest of human fibrinogen. The major polypeptide species has 91 amino acid residues, although a small amount of a 97-residue chain representing an earlier digestion stage remains. The amino acid sequence of the first 44 residues was determined by stepwise degradation with an automatic solid-phase sequencer. Another large stretch of sequence was revealed by the finding that the alpha chain of fragment D overlaps the cyanogen bromide fragments alphaCNIVA and alphaCNIII (Doolittle, R. F. Cassman, K. G., Cottrell, B. A., Friezner, S. J. Hucko, J. T., and Takagi, T. (1977), Biochemistry 16 (preceding paper in this issue)). The automatic sequencer results were confirmed and extended by the isolation and characterization of 18 of 19 expected tryptic peptides from the fragment D alpha chain. As a result, almost the entire sequence has been obtained. The overlap with key cyanogen bromide fragments has also allowed us to propose an order for the first 198 residues of the fibrinogen alpha chain. A striking homology with the gamma chain and beta chain is apparent which has interesting structural implications.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 139916     DOI: 10.1021/bi00627a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Secondary structure of component 8c-1 of alpha-keratin. An analysis of the amino acid sequence.

Authors:  L M Dowling; W G Crewther; D A Parry
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

2.  The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".

Authors:  M W Mosesson; K R Siebenlist; J f Hainfeld; J S Wall; J Soria; C Soria; J P Caen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

3.  Amino acid sequence of the beta chain of human fibrinogen: homology with the gamma chain.

Authors:  K W Watt; T Takagi; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

4.  Bacteroides gingivalis and Bacteroides intermedius recognize different sites on human fibrinogen.

Authors:  M S Lantz; R D Allen; P Bounelis; L M Switalski; M Hook
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

5.  Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway.

Authors:  D G Ritchie; B A Levy; M A Adams; G M Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  A negative blood-clotting factor lining the vessels.

Authors:  E Heymann; R Mentlein
Journal:  Naturwissenschaften       Date:  1982-04

7.  Shadow-cast electron microscopy of fibrinogen with antibody fragments bound to specific regions.

Authors:  T M Price; D D Strong; M L Rudee; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Characterization of the inhibition of fibrin assembly by fibrinogen fragment D.

Authors:  J E Williams; R R Hantgan; J Hermans; J McDonagh
Journal:  Biochem J       Date:  1981-09-01       Impact factor: 3.857

9.  Determination of fragment D-dimer derivatives in serum reactive with antiserum against human fragment D-dimer.

Authors:  A Matsushima; A Shimizu; Y Takahama; T Tsukada; Y Inada
Journal:  Blut       Date:  1984-08

10.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.